Wattana Karnpaet PCL (BKK:NEW) 3-Year RORE % : -24.31% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:NEW Wattana Karnpaet PCL BKK:NEW
81 GF Score
Price ฿104.00
GF Value ฿96.97
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Wattana Karnpaet PCL 3-Year RORE %?

Wattana Karnpaet PCL BKK:NEW +7.77% 81 3-Year RORE % is -24.31 as of Mar. 2026. GuruFocus rates BKK:NEW with a GF Score™ of 81/100 and a GF Value™ of ฿96.97 (Fairly Valued). The stock has 2 warning signs investors should review. Among 603 Healthcare Providers & Services companies, Wattana Karnpaet PCL ranks worse than 69.98% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Wattana Karnpaet PCL's 3-Year RORE % for the quarter that ended in Mar. 2026 was -24.31%.

The industry rank for Wattana Karnpaet PCL's 3-Year RORE % or its related term are showing as below:

BKK:NEW's 3-Year RORE % is ranked worse than
69.98% of 603 companies
in the Healthcare Providers & Services industry
Industry Median: 0.07 vs BKK:NEW: -24.31

Wattana Karnpaet PCL  (BKK:NEW) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Wattana Karnpaet PCL 3-Year RORE % Related Terms


Wattana Karnpaet PCL 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Wattana Karnpaet PCL's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wattana Karnpaet PCL 3-Year RORE % Chart

Wattana Karnpaet PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -45.92 93.86 39.08 -42.17 -29.69

Wattana Karnpaet PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.50 -37.62 -24.42 -29.69 -24.31

BKK:NEW vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Wattana Karnpaet PCL's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wattana Karnpaet PCL 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Wattana Karnpaet PCL's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Wattana Karnpaet PCL's 3-Year RORE % falls into.


BKK:NEW
81GF Score
Wattana Karnpaet PCL BKK:NEW
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wattana Karnpaet PCL 3-Year RORE % Calculation

Wattana Karnpaet PCL's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 4.07-5.356 )/( 13.39-8.1 )
=-1.286/5.29
=-24.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -24.31 mean?
Wattana Karnpaet PCL (BKK:NEW) has a 3-Year RORE % of -24.31 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Wattana Karnpaet PCL and its competitors. According to the industry distribution chart, Wattana Karnpaet PCL ranks #422 out of 603 companies in the Healthcare Providers & Services industry, placing it in the top 70%.
Is Wattana Karnpaet PCL's 3-Year RORE % too high?
Wattana Karnpaet PCL's current 3-Year RORE % is -24.31. Based on the distribution chart, Wattana Karnpaet PCL ranks #422 out of 603 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Wattana Karnpaet PCL has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wattana Karnpaet PCL's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wattana Karnpaet PCL ranks #422 out of 603 companies for 3-Year RORE %. This places Wattana Karnpaet PCL in the lower half of its industry. The industry median 3-Year RORE % is 0.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.07, based on 603 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Wattana Karnpaet PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wattana Karnpaet PCL's current 3-Year RORE % is -24.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattana Karnpaet PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattana Karnpaet PCL (BKK:NEW) is currently considered Fairly Valued. The stock's GF Value™ is ฿96.97, compared to a current price of ฿104.00 — trading 7.2% above its estimated fair value. The current 3-Year RORE % is -24.31. Wattana Karnpaet PCL's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Wattana Karnpaet PCL (BKK:NEW), the current 3-Year RORE % is -24.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wattana Karnpaet PCL (BKK:NEW) Overvalued in 2026?

Based on GuruFocus' analysis, Wattana Karnpaet PCL stock appears to be overvalued. The current stock price of ฿104.00 is trading 7.2% above its estimated GF Value™ of ฿96.97. GuruFocus considers Wattana Karnpaet PCL to be Fairly Valued.

Key valuation signals for BKK:NEW:

  • 3-Year RORE %: -24.31
  • GF Value™: ฿96.97 vs. price of ฿104.00 (7.2% above fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the BKK:NEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Wattana Karnpaet PCL Business Description

Address 70/7-8 Suphakitjanya Road, Mhakkang sub-district, Muang Udonthanee district, Udonthanee, THA, 41000
Wattana Karnpaet PCL is engaged in the operation of a hospital under the name North Eastern Wattana Hospital. It has a single segment of operation, namely the hospital and medical trading business. The company earns revenue from hospital, revenue from sales of medicines, and revenue from hospital rooms, which are derived from the provision of services to various types and a large number of customers. Geographically, the company's operations are carried out in Thailand.
81GF Score

Get the complete analysis for BKK:NEW

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿104.00
Price
฿96.97
GF Value